Healthcare entity
acquisition is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Keytruda, the most common co-covered peer. The 8 average consequence score is above the beat benchmark of 6.6 in the same window.
Last mentioned: Mar 25, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
acquisition is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Keytruda, the most common co-covered peer. The 8 average consequence score is above the beat benchmark of 6.6 in the same window. Each story carries 2 original sources on average, compared with 3.3 for the broader beat in this window. Scemblix appears in 1 tracked Healthcare story from March 25, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 26 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Scemblix. Shared-story counts are live from our verified record — not editorial picks.
Keytruda Patent Cliff
Merck faces the loss of exclusivity for its top-selling cancer immunotherapy.
Expected Closing
Anticipated completion of the acquisition following regulatory reviews.
Acquisition Announcement
Merck announces definitive agreement to buy Terns for $6.7 billion.
Clinical Progress
Terns Pharmaceuticals advances TERN-701 through early-stage clinical trials for CML.
Merck has reached a definitive agreement to acquire Terns Pharmaceuticals for $6.7 billion, securing a promising Phase 2 leukemia treatment. The cash deal is a strategic move to diversify Merck's oncology portfolio as it prepares for the 2028 patent expiration of its blockbuster drug Keytruda.
Scemblix is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
